Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835Open textbooks209Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Digestive System and Liver›Stomach Ulcer

Continue where you left off ()

Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Stomach Ulcer

Digestive System and Liver · NLM MeSH · updated 2026-11-04 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 4 min read

Ulceration of the gastric mucosa due to contact with gastric juice.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (846 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

Ulceration of the gastric mucosa due to contact with gastric juice. It is often associated with helicobacter pylori infection or consumption of nonsteroidal anti-inflammatory drugs (nsaids).

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Stomach Ulcers; Ulcers, Stomach; Ulcer, Stomach; Gastric Ulcer; Gastric Ulcers; Ulcer, Gastric; Ulcers, Gastric.

Where it fits in the MeSH classification

Broader topics
Peptic Ulcer

Related concepts

  • Gastric Mucosa
  • Gastric Juice
  • Helicobacter Pylori
  • Nsaids

Research landscape

PubMed indexes 27,557 records tagged with the MeSH heading “Stomach Ulcer” (counts retrieved 2026-11-04). 1,313 of them (4.8%) were published from 2020 onward, and the busiest period so far is through 1999 with 19,885 records.

Reviews account for 2,066 records (7.5%) and meta-analyses for 77. Randomized controlled trials number 815 (3.0%) as a share of all records on the topic.

PubMed records by publication periodthrough 1999: 19,885 records; 2000-2009: 3,638 records; 2010-2019: 2,721 records; 2020 onward: 1,313 records19,885through 19993,6382000-20092,7212010-20191,3132020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 199919,885
2000-20093,638
2010-20192,721
2020 onward1,313
Share of records by publication typeReviews: 7.5 percent; Meta-analyses: 0.3 percent; Randomized controlled trials: 3.0 percentReviews7.5% (2,066)Meta-analyses0.3% (77)Randomized controlled trials3.0% (815)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 27,557 PubMed records
TypeRecordsShare
Reviews2,0667.5%
Meta-analyses770.3%
Randomized controlled trials8153.0%

Method: PubMed query "Stomach Ulcer"[MeSH Terms] with publication-type and date filters, retrieved 2026-11-04.

Reading the evidence in digestive system and liver

Gut and liver research ranges from laboratory studies of the microbiome to large trials of drugs and surgery. Symptoms such as pain, reflux or bowel change are reported by patients and overlap between conditions, and diet and microbiome studies are mostly observational. Check whether the study measured symptoms, tissue findings or long-term outcomes, how the diagnosis was made and how long people were followed. Nothing here replaces advice from a qualified clinician.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Antiulcerogenic effect of Cuphea ignea extract against ethanol-induced gastric ulcer in rats
Mousa AM, El-Sammad NM, Hassan SK, Madboli AENA, Hashim AN, Moustafa ES, et al.
2019Research article
Design not recorded in structured metadata
61cc by
PMID 31791313 · DOI · PMC6888969
Protective Effects of Piperine on Ethanol-Induced Gastric Mucosa Injury by Oxidative Stress Inhibition
Duan Z, Yu S, Wang S, Deng H, Guo L, Yang H, et al.
2022Research article
Design not recorded in structured metadata
42cc by
PMID 36432431 · DOI · PMC9695505
Formulation, optimization and characterization of allantoin-loaded chitosan nanoparticles to alleviate ethanol-induced gastric ulcer: in-vitro and in-vivo studies
Aman RM, Zaghloul RA, El-Dahhan MS
2021Research article
Design not recorded in structured metadata
40cc by
PMID 33500454 · DOI · PMC7838192
Anti-Helicobacter pylori Activity and Gastroprotective Effects of Diacetylcurcumin and Four Metal Derivatives
Agabo-Martínez A, Gomez-Chang E, Hernández-Hipólito E, Estrada-Muñiz E, Escobedo-Martínez C, Obregón-Mendoza MA, et al.
2025Research article
Design not recorded in structured metadata
0cc by
PMID 41097273 · DOI · PMC12525688

Antiulcerogenic effect of Cuphea ignea extract against ethanol-induced gastric ulcer in rats [1]

Research article Mousa AM, El-Sammad NM, Hassan SK, Madboli AENA, Hashim AN, Moustafa ES, et al. · · 2019 · cited 61 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundCuphea ignea is one of the herbal resources belonging to Lythraceae family.
Closing excerpt
ignea extract showed a potential gastroprotective effect on ethanol-induced gastric ulcer, and its effect may be mediated through suppression of oxidative stress and gastric inflammation.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (270 words)

BackgroundCuphea ignea is one of the herbal resources belonging to Lythraceae family. Some species of this family have been used traditionally in South and Central America's folk medicine for treating stomach disorders. Therefore, the present study was performed to evaluate the gastropreventive effect of aqueous ethanolic extract of C. ignea aerial parts on ethanol-induced gastric ulcer.MethodsGastric ulcers were induced in Sprague Dawley rats using one oral dose of absolute ethanol (1.5 mL/rat). The C. ignea aerial parts extract at doses of 250 and 500 mg/kg body weight and ranitidine (a reference drug) at a dose of 30 mg/kg body weight were orally administrated daily for 7 days before ulcer induction. One hour after ethanol administration blood samples were collected and then stomachs of sacrificed rats were subjected to biochemical, macroscopic and microscopic studies.ResultsOral administration of C. ignea extract significantly attenuated gastric ulcer as revealed by significant reduction in the gastric ulcer index and volume of gastric juice while significantly increased preventive percentage, gastric pH value and pepsin activity. Pre-treatment of C. ignea extract markedly improved the serum level of TNF-α, the gastric MPO activity and NO content. Furthermore, C. ignea pre-treatment significantly increased the gastric levels of enzymatic and non- enzymatic antioxidants namely CAT, SOD, GSH-Px, and GSH with concomitant reduction in MDA level compared with those in the ethanol group. These results were further supported by histopathological findings which revealed the curing effect of C. ignea on the hemorrhagic shock induced by ethanol toxicity.ConclusionsC. ignea extract showed a potential gastroprotective effect on ethanol-induced gastric ulcer, and its effect may be mediated through suppression of oxidative stress and gastric inflammation.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 31791313 · DOI · PMC6888969

Protective Effects of Piperine on Ethanol-Induced Gastric Mucosa Injury by Oxidative Stress Inhibition [2]

Research article Duan Z, Yu S, Wang S, Deng H, Guo L, Yang H, et al. · · 2022 · cited 42 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Piper nigrum Linnaeus is often used as a treatment for chills, stomach diseases, and other ailments.
Closing excerpt
In conclusion, piperine suppressed ethanol-induced gastric ulcers in vitro and in vivo via oxidation inhibition and improving gastric-protecting activity by regulating the Nrf2/HO-1 and MAPK signalling pathways.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (175 words)

Piper nigrum Linnaeus is often used as a treatment for chills, stomach diseases, and other ailments. Piperine has many biological functions; however, its mechanism for preventing gastric mucosal damage is still unclear. The objective of this study was to investigate the preventive effects of piperine on ethanol-induced gastric mucosal injury by using GES-1 cells and rats. SOD, CAT, GSH-Px and MDA were effectively regulated in GES-1 cells pre-treated with piperine. Piperine significantly increased SOD, CAT and GSH-Px activities, but decreased the ulcer area, MDA, ROS and MPO levels in the gastric tissues of rats. RT-PCR analysis showed that piperine downregulated the mRNA expression levels of keap1, JNK, ERK and p38, and upregulated the mRNA transcription levels of Nrf2 and HO-1. Western blotting results indicated that piperine could activate the protein expression levels of Nrf2 and HO-1 and inhibit the protein expression levels of keap1, p-JNK, p-ERK and p-p38. In conclusion, piperine suppressed ethanol-induced gastric ulcers in vitro and in vivo via oxidation inhibition and improving gastric-protecting activity by regulating the Nrf2/HO-1 and MAPK signalling pathways.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 36432431 · DOI · PMC9695505

Formulation, optimization and characterization of allantoin-loaded chitosan nanoparticles to alleviate ethanol-induced gastric ulcer: in-vitro and in-vivo studies [3]

Research article Aman RM, Zaghloul RA, El-Dahhan MS · · 2021 · cited 40 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Allantoin (ALL) is a phytochemical possessing an impressive array of biological activities.
Closing excerpt
In conclusion, the prepared ALL-loaded CS/STPP NPs could be presented to the phytomedicine field as an auspicious oral delivery system for gastric ulceration management.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (200 words)

Allantoin (ALL) is a phytochemical possessing an impressive array of biological activities. Nonetheless, developing a nanostructured delivery system targeted to augment the gastric antiulcerogenic activity of ALL has not been so far investigated. Consequently, in this survey, ALL-loaded chitosan/sodium tripolyphosphate nanoparticles (ALL-loaded CS/STPP NPs) were prepared by ionotropic gelation technique and thoroughly characterized. A full 24 factorial design was adopted using four independently controlled parameters (ICPs). Comprehensive characterization, in vitro evaluations as well as antiulcerogenic activity study against ethanol-induced gastric ulcer in rats of the optimized NPs formula were conducted. The optimized NPs formula, (CS (1.5% w/v), STPP (0.3% w/v), CS:STPP volume ratio (5:1), ALL amount (13 mg)), was the most convenient one with drug content of 6.26 mg, drug entrapment efficiency % of 48.12%, particle size of 508.3 nm, polydispersity index 0.29 and ζ-potential of + 35.70 mV. It displayed a sustained in vitro release profile and mucoadhesive strength of 45.55%. ALL-loaded CS/STPP NPs (F-9) provoked remarkable antiulcerogenic activity against ethanol-induced gastric ulceration in rats, which was accentuated by histopathological, immunohistochemical (IHC) and biochemical studies. In conclusion, the prepared ALL-loaded CS/STPP NPs could be presented to the phytomedicine field as an auspicious oral delivery system for gastric ulceration management.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 33500454 · DOI · PMC7838192

Anti-Helicobacter pylori Activity and Gastroprotective Effects of Diacetylcurcumin and Four Metal Derivatives [4]

Research article Agabo-Martínez A, Gomez-Chang E, Hernández-Hipólito E, Estrada-Muñiz E, Escobedo-Martínez C, Obregón-Mendoza MA, et al. · · 2025

Abstract reading summary — source excerpts
Opening excerpt
Helicobacter pylori is the main etiological factor of gastritis, peptic ulcers, and gastric cancer.
Closing excerpt
pylori eradication schemes.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (201 words)

Helicobacter pylori is the main etiological factor of gastritis, peptic ulcers, and gastric cancer. This bacterium's antibiotic resistance has led to a lower eradication rate; therefore, new drugs with anti-H. pylori activity are needed. Curcumin exhibits multiple biological activities, but it has low stability and poor bioavailability. To overcome these disadvantages, different metal complexes have been synthesized. The objective of this study was to determine the in vitro anti-H. pylori activity of diacetylcurcumin (DAC), DAC2-Cu, DAC2-Zn, DAC2-Mn, and DAC2-Mg by obtaining the minimum inhibitory concentration of bacterial growth, and to investigate some mechanisms by which they could affect the bacteria (urease and DNA gyrase activities). Moreover, their gastroprotective potential was assayed in an ethanol-induced gastric ulcer model in mice. The results showed that DAC2-Cu and DAC2-Zn have good anti-H. pylori activity, exhibit specific activity against this bacterium, inhibit the urease activity, and provide 70% gastroprotection at a dose of 200 mg/kg of body weight. In a subacute toxicity study in mice, DAC2-Cu and DAC2-Zn did not cause death or any deleterious symptoms, nor did they have a significant effect on serum and urine biochemical parameters compared to control mice. These compounds are promising candidates for use in H. pylori eradication schemes.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41097273 · DOI · PMC12525688

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Cellular and molecular mechanisms of gastrointestinal ulcer healing [5]
    Tarnawski AS · Dig Dis Sci · 2005 · cited 292 times (Europe PMC)
  • Research article History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer [6]
    Graham DY · World J Gastroenterol · 2014 · cited 216 times (Europe PMC)
  • Research article Nonsteroidal anti-inflammatory drug gastropathy [7]
    Hawkey CJ · Gastroenterology · 2000 · cited 203 times (Europe PMC)
  • Research article European College of Equine Internal Medicine Consensus Statement--Equine Gastric Ulcer Syndrome in Adult Horses [8]
    Sykes BW, Hewetson M, Hepburn RJ, Luthersson N, Tamzali Y · J Vet Intern Med · 2015 · cited 182 times (Europe PMC)
  • Research article Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis [9]
    Alhazzani W, Alenezi F, Jaeschke RZ, Moayyedi P, Cook DJ · Crit Care Med · 2013 · cited 144 times (Europe PMC)
  • Research article Development of ulcer disease after Roux-en-Y gastric bypass, incidence, risk factors, and patient presentation: a systematic review [10]
    Coblijn UK, Goucham AB, Lagarde SM, Kuiken SD, van Wagensveld BA · Obes Surg · 2014 · cited 138 times (Europe PMC)

References

  1. Mousa AM, El-Sammad NM, Hassan SK, Madboli AENA, Hashim AN, Moustafa ES, et al.. Antiulcerogenic effect of Cuphea ignea extract against ethanol-induced gastric ulcer in rats. . 2019. PMID 31791313 · DOI · PMC6888969
  2. Duan Z, Yu S, Wang S, Deng H, Guo L, Yang H, et al.. Protective Effects of Piperine on Ethanol-Induced Gastric Mucosa Injury by Oxidative Stress Inhibition. . 2022. PMID 36432431 · DOI · PMC9695505
  3. Aman RM, Zaghloul RA, El-Dahhan MS. Formulation, optimization and characterization of allantoin-loaded chitosan nanoparticles to alleviate ethanol-induced gastric ulcer: in-vitro and in-vivo studies. . 2021. PMID 33500454 · DOI · PMC7838192
  4. Agabo-Martínez A, Gomez-Chang E, Hernández-Hipólito E, Estrada-Muñiz E, Escobedo-Martínez C, Obregón-Mendoza MA, et al.. Anti-Helicobacter pylori Activity and Gastroprotective Effects of Diacetylcurcumin and Four Metal Derivatives. . 2025. PMID 41097273 · DOI · PMC12525688
  5. Tarnawski AS. Cellular and molecular mechanisms of gastrointestinal ulcer healing. Dig Dis Sci. 2005. PMID 16184417 · DOI
  6. Graham DY. History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer. World J Gastroenterol. 2014. PMID 24833849 · DOI · PMC4017034
  7. Hawkey CJ. Nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology. 2000. PMID 10930388 · DOI
  8. Sykes BW, Hewetson M, Hepburn RJ, Luthersson N, Tamzali Y. European College of Equine Internal Medicine Consensus Statement--Equine Gastric Ulcer Syndrome in Adult Horses. J Vet Intern Med. 2015. PMID 26340142 · DOI · PMC4858038
  9. Alhazzani W, Alenezi F, Jaeschke RZ, Moayyedi P, Cook DJ. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis. Crit Care Med. 2013. PMID 23318494 · DOI
  10. Coblijn UK, Goucham AB, Lagarde SM, Kuiken SD, van Wagensveld BA. Development of ulcer disease after Roux-en-Y gastric bypass, incidence, risk factors, and patient presentation: a systematic review. Obes Surg. 2014. PMID 24234733 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-11-04; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-11-04.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Peptic UlcerDigestive System and Liver
  • Gastric Outlet ObstructionDigestive System and Liver
  • Gastric DilatationDigestive System and Liver
  • GastroparesisDigestive System and Liver
  • EnterocolitisDigestive System and Liver
  • DuodenitisDigestive System and Liver

All 66 articles in Digestive System and Liver →

At a glance

27,557
PubMed records on this heading
5%
published since 2020
2,066
review articles
815
randomized trials
10
verified references below

Counts come from PubMed on 2026-11-04; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Peptic UlcerDigestive System and Liver
  • Gastric Outlet ObstructionDigestive System and Liver
  • Gastric DilatationDigestive System and Liver
  • GastroparesisDigestive System and Liver
  • EnterocolitisDigestive System and Liver

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support